Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Sheryl Vondracek

Concepts (122)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteoporosis
5
2009
239
1.090
Why?
Antihypertensive Agents
2
2018
519
0.750
Why?
Vitamin D
6
2012
402
0.750
Why?
Nephrologists
1
2021
13
0.680
Why?
Bone Density Conservation Agents
3
2010
82
0.600
Why?
Hypertension
2
2018
1270
0.550
Why?
Labetalol
1
2018
6
0.540
Why?
Adrenergic Antagonists
1
2018
5
0.540
Why?
Hydralazine
1
2018
6
0.540
Why?
Vitamin D Deficiency
5
2012
188
0.540
Why?
Glomerular Filtration Rate
1
2021
743
0.520
Why?
Kidney Diseases
1
2021
427
0.500
Why?
Asymptomatic Diseases
1
2016
102
0.470
Why?
Vasodilator Agents
1
2018
326
0.460
Why?
Pulmonary Disease, Chronic Obstructive
3
2009
926
0.450
Why?
Ergocalciferols
2
2012
15
0.440
Why?
Bone Density
4
2015
492
0.410
Why?
Curriculum
1
2021
1074
0.410
Why?
Kidney
1
2021
1491
0.390
Why?
Glucocorticoids
2
2006
536
0.340
Why?
Receptors, Calcitriol
1
2011
54
0.330
Why?
Blood Pressure
1
2018
1761
0.330
Why?
Prescription Drugs
1
2012
110
0.310
Why?
Hospitalization
2
2018
2468
0.310
Why?
Body Composition
2
2015
686
0.310
Why?
Osteoporosis, Postmenopausal
1
2010
41
0.300
Why?
Adipokines
1
2009
56
0.290
Why?
Geriatric Nursing
1
2009
23
0.280
Why?
Premenopause
1
2009
129
0.270
Why?
Risk Reduction Behavior
1
2010
219
0.270
Why?
Administration, Intravenous
2
2018
172
0.240
Why?
Kidney Failure, Chronic
1
2011
582
0.220
Why?
Prednisone
1
2006
229
0.220
Why?
Acute Disease
3
2018
1033
0.200
Why?
Hospitals, University
2
2018
176
0.180
Why?
Severity of Illness Index
3
2018
2910
0.160
Why?
Drug Therapy, Combination
3
2015
1034
0.140
Why?
Absorptiometry, Photon
2
2009
276
0.130
Why?
Drug Utilization Review
1
2018
60
0.130
Why?
Aged
8
2018
26251
0.130
Why?
Electronic Health Records
2
2018
1208
0.120
Why?
Humans
18
2021
145625
0.120
Why?
Vitamins
2
2008
183
0.120
Why?
Time Factors
2
2018
7079
0.120
Why?
Pharmacists
2
2010
260
0.120
Why?
Blood Pressure Determination
1
2016
143
0.110
Why?
Estrogens, Conjugated (USP)
1
2015
52
0.110
Why?
Administration, Oral
1
2018
867
0.110
Why?
Aged, 80 and over
5
2012
8351
0.110
Why?
Drug Administration Schedule
2
2006
782
0.100
Why?
Gonadotropin-Releasing Hormone
1
2015
215
0.100
Why?
Fractures, Bone
2
2009
431
0.100
Why?
Drug Evaluation
1
2012
78
0.090
Why?
Female
10
2018
79080
0.090
Why?
Colorado
4
2018
4588
0.090
Why?
Dose-Response Relationship, Drug
2
2015
2018
0.090
Why?
Professional Role
2
2010
171
0.080
Why?
Prevalence
2
2016
2852
0.080
Why?
Cholecalciferol
1
2011
60
0.080
Why?
Bone Resorption
1
2011
80
0.080
Why?
Exercise
2
2015
2206
0.080
Why?
Contraindications
1
2010
88
0.080
Why?
Retrospective Studies
3
2018
17291
0.080
Why?
Bone Remodeling
1
2010
71
0.080
Why?
Resistin
1
2009
12
0.070
Why?
Male
8
2018
73014
0.070
Why?
Biological Factors
1
2009
39
0.070
Why?
Practice Guidelines as Topic
1
2016
1581
0.070
Why?
Practice Patterns, Physicians'
1
2018
1370
0.070
Why?
Raloxifene Hydrochloride
1
2008
15
0.070
Why?
Leptin
1
2009
247
0.070
Why?
Hip Joint
1
2009
172
0.070
Why?
Adult
4
2018
40821
0.060
Why?
Adiponectin
1
2009
243
0.060
Why?
Diphosphonates
1
2008
67
0.060
Why?
Lumbar Vertebrae
1
2009
259
0.060
Why?
Community Pharmacy Services
1
2007
46
0.060
Why?
Risk Assessment
1
2016
3678
0.060
Why?
Accreditation
1
2007
100
0.060
Why?
Middle Aged
3
2018
36359
0.060
Why?
Women's Health
1
2009
317
0.060
Why?
Calcium
2
2010
1181
0.060
Why?
Hospital Bed Capacity, 300 to 499
1
2006
3
0.060
Why?
Drug Administration Routes
1
2006
41
0.060
Why?
Life Style
1
2009
495
0.060
Why?
Pharmacy Service, Hospital
1
2007
90
0.060
Why?
Preceptorship
1
2006
68
0.060
Why?
Education, Pharmacy
1
2007
124
0.060
Why?
Treatment Outcome
2
2018
11744
0.060
Why?
Drug Utilization
1
2006
170
0.050
Why?
Students, Pharmacy
1
2006
96
0.050
Why?
Tumor Necrosis Factor-alpha
1
2009
1223
0.050
Why?
Risk Factors
3
2009
10840
0.050
Why?
Pilot Projects
1
2009
1878
0.050
Why?
Patient Education as Topic
1
2008
769
0.050
Why?
Educational Measurement
1
2006
329
0.050
Why?
Recurrence
1
2006
1125
0.050
Why?
Clinical Trials as Topic
1
2006
1062
0.040
Why?
Mass Screening
1
2009
1300
0.040
Why?
Cross-Sectional Studies
2
2009
5875
0.040
Why?
Diet
1
2007
1271
0.040
Why?
Clinical Competence
1
2007
1261
0.040
Why?
Parathyroid Hormone
2
2008
118
0.030
Why?
Lung
1
2009
4119
0.030
Why?
Prognosis
1
2004
4331
0.030
Why?
Young Adult
1
2012
14240
0.030
Why?
Ovary
1
2015
235
0.020
Why?
Ambulatory Care
2
2008
627
0.020
Why?
Adolescent
1
2012
22451
0.020
Why?
Self Administration
1
2008
121
0.020
Why?
Pharmaceutical Services
1
2008
76
0.020
Why?
Nutrition Policy
1
2007
56
0.020
Why?
Phosphorus
1
2007
89
0.020
Why?
Nonprescription Drugs
1
2007
68
0.010
Why?
Serum Albumin
1
2007
147
0.010
Why?
Schools, Pharmacy
1
2006
48
0.010
Why?
Creatinine
1
2007
511
0.010
Why?
Outpatients
1
2007
437
0.010
Why?
Age Factors
1
2007
3321
0.010
Why?
Follow-Up Studies
1
2008
5397
0.010
Why?
Prospective Studies
1
2007
8087
0.010
Why?
Obesity
1
2007
3123
0.010
Why?
Vondracek's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)